Botulinum Toxin in the Treatment of Muscle Specific Oro-Facial Pain: A Literature Review

DuBrul EL (1980) Sicher’s oral anatomy. 7th ed. C.V. Mosby, St. Louis (MO), p 146–61, 174–209 Carlsson GE (1999) Epidemiology and treatment need for temporomandibular disorders. J Orofac Pain 13:232–237 Bentsianov B et al (2004) Botulinum toxin treatment for TMD. Operative Tech Otolaryngol Head Neck Surg 15(2):110–113 Schwartz M, Freund B (2002) Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain 18(suppl 6):S198–S203 Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F (2011) Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I: epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(4):453–462 Herb et al (2006) Temporomandibular joint pain and dysfunction. Curr Pain Headache Rep 10:408–414 Freund B, Schwartz M, Symington JM (2000) Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg 38:466–471 Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155–188 Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044 Jankovic J (1986) Blepharospasm with basal ganglia lesions. Arch Neurol 43:866 Jankovic J, Fahn S (1988) Dystonic syndromes. In: Jankovic J, Tolosa E (eds) Parkinson’s Disease and Movement Disorders. Urban & Schwarzenberg, Baltimore, MD, pp 283–314 Jankovic J, Orman J (1987) Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology 37:616 Blitzer A, Brin MF, Green PE et al (1989) Botulinum toxin injection for the treatment of oromandibular dystonia. Trans Am Laryngol Assoc San Francisco 110(April):1–2 Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155–188 Brin MF (1997) Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 6:S146–S168 Wheeler AH (2004) Myofascial pain disorders: theory to therapy. Drugs 64(1):45–62 Göbel H (2003) Jost WH: Botulinum toxin in specific pain therapy. Schmerz 17:149–165 Schwartz M, Freund B (2002) Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain 18(suppl 6):S198–S203 Girdler NM (1994) Use of botulinum toxin to alleviate facial pain (letter). Br J Hosp Med 52:363 von Lindern JJ, Niederhagen B, Appel T et al (2001) Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment. Plast Reconstr Surg 107:327–332 von Lindern JJ, Niederhagen B, Berge S et al (2003) Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 61:774–778 Isaac AM, Moss CE, Whear NM (2000) Unilateral temporalis muscle hypertrophy managed with botulinum toxin type-A. Br J Oral Maxillofac Surg 38:571–2. Comments in: Br J Oral Maxillofac Surg 2001;39:483 To EW, Ahuja AT, Ho WS et al (2001) A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement. Br J Plast Surg 54:197–200 Moore AP, Wood GD (1997) Medical treatment of recurrent temporomandibular joint dislocation using botulinum toxin A. Br Dent J 183:415–417 Daelen B, Thorwirth V, Koch A (1997) Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin. Int J Oral Maxillofac Surg 26:458–460 Bakke M, Moller E, Werdelin LM, Dalager T, Kitai N, Kreiborg S (2005) Treatment of severe temporomandibular joint clicking with botulinum toxin in the lateral pterygoid muscle in two cases of anterior disc displacement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:693–700 Karacalar A, Yilmaz N, Bilgici A, Baş B, Akan H (2005) Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience. J Craniofac Surg 16:476–481 Arinci Atilla et al (2005) Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint. J Cranf Surg 19:122 Blitzer A, Brin MF, Greene PE, Fahn S (1989) Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol 98:93–97 Van Zandijcke M, Marchau MM (1990) Treatment of bruxism with botulinum toxin injections. J Neurol Neurosurg Psychiatry 53:530 Tan EK, Jankovic J (2000) Treating severe bruxism with botulinum toxin. J Am Dent Assoc 131:211–216 Monroy PG, da Fonseca MA (2006) The use of botulinum toxin-A in the treatment of severe bruxism in a patient with autism: a case report. Spec Care Dentist 26:37–39 Guarda-Nardini L, Manfredini D, Salamone M et al (2008) Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Cranio 26:126–135 Eleopra R, Tugnoli V, Caniatti L, De Grandis D (1996) Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion. Neurology 46:1158–1160 Song PC, Schwartz J, Blitzer A (2007) The emerging role of botulinum toxin in the treatment of temporomandibular disorders. Oral Dis 13:253–260 Lee EH, Kim JY, Kweon HY, Jo YY, Min SK, Park YW et al (2010) A combination graft of low-molecular-weight silk fibroin with Choukroun’s platelet-rich fibrin for rabbit calvarial defect. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109:e33–e38